AT470713T - POLYPEPTIDE VARIANTS WITH RAISED HEPARIN-BINDING CAPACITY

20 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims
Document	Office	Kind	Date
19906096	Germany	A	1999-02-13
0000637	European Patent Office (EPO)	W	2000-01-27

Family members, oldest first
Document	Office	Kind
CA2362496A1	Canada	A1	2000-08-17
DE19906096A1	Germany	A1	2000-08-17
WO0047736A1	World Intellectual Property Organization (WIPO)	A1	2000-08-17
AU2110600A	Australia	A	2000-08-29
BR0008785A	Brazil	A	2001-11-06
EP1151095A1	European Patent Office (EPO)	A1	2001-11-07
CN1340102A	China	A	2002-03-13
JP2002536016A	Japan	A	2002-10-29
AU762387B2	Australia	B2	2003-06-26
RU2227743C2	Russian Federation	C2	2004-04-27
CN1169959C	China	C	2004-10-06
US7253254B1	United States of America	B1	2007-08-07
JP2008086319A	Japan	A	2008-04-17
JP4155711B2	Japan	B2	2008-09-24
JP2009011323A	Japan	A	2009-01-22
EP1151095B1	European Patent Office (EPO)	B1	2010-06-09
AT470713TThis record	Austria	T	2010-06-15
ATE470713T1	Austria	T1	2010-06-15
DE50015938D1	Germany	D1	2010-07-22
CA2362496C	Canada	C	2011-04-19

1 legal event, as the office reported them to INPADOC

Legal events, newest first
	Event	Code
2012-04-15	Ceased due to non-payment of the annual feeCeasedREN	REN

CPC, 14: C07K14/51
A61K38/00
A61P9/00
C07K2319/00
A61P13/12
A61P17/02
A61P19/00
A61P19/02
A61P19/08
A61P19/10
A61P25/00
A61P29/00
A61P35/00
A61P43/00
Filled: the office’s first classification
IPC, 24: A61K31 70
A61K31 727
A61K38 00
A61K38 18
A61K47 04
A61K47 30
A61K47 36
A61K47 42
A61K47 48
A61P17 02
A61P19 00
A61P19 08
A61P29 00
A61P35 00
C07K14 47
C07K14 51
C07K7 08
C12N1 15
C12N1 19
C12N15 09
C12N15 12
C12N15 62
C12N5 10
C12P21 02

Polypeptide variants with raised heparin-binding capacity